Search Within

Roni Tamari

Formats
  1. Meeting Abstract (124)
  2. Journal Article (75)
  3. Research Letter (7)
  4. Review (6)
  5. Book Section (1)
Groups
  1. Bone Marrow Transplant (213)
  2. CTCR Scholars (213)
  3. Center for Hematologic Malignancies (213)
  4. Department of Medicine (213)
  5. Hematologic Malignancies, Division of (213)
  6. MSK Grad Students (213)

More Groups

People
  1. Sergio Giralt (160)
  2. Miguel-Angel Perales (140)
  3. Ann Jakubowski (123)
  4. Esperanza Papadopoulos (120)
  5. Sean Devlin (99)
  6. Brian Shaffer (88)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (22)
  4. 2022 (26)
  5. 2021 (23)
  6. 2020 (28)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (68)
  2. Blood (54)
  3. Bone Marrow Transplantation (24)
  4. Transplantation and Cellular Therapy (17)
  5. Blood Advances (12)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (87)
  2. American Society of Hematology (66)
  3. Nature Publishing Group (26)
  4. American Society of Clinical Oncology (4)
  5. Oxford University Press (4)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (213)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Human herpesvirus 6 DNAemia is associated with worse survival after ex vivo T-cell-depleted hematopoietic cell transplant
    Journal Article

    Lee, Y. J.; Su, Y.; Cho, C.; Tamari, R.; Perales, M. A.; Jakubowski, A. A.; Papanicolaou, G. A.
    Journal of Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of eprenetapopt (APR-246) in combination with azacitidine (AZA) as maintenance therapy for TP53 mutated AML or MDS following allogeneic stem cell transplantation (SCT)
    Meeting Abstract

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Gallacher, P.; Wennborg, A.; Hickman, D. K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase II study of ruxolitinib pre-, during- and post-hematopoietic celltransplantation for patients with primary or secondary myelofibrosis
    Meeting Abstract

    Hobbs, G.; Kim, H. T.; Bottoms, A. J. S.; Byrne, M. T.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; Defilipp, Z.; El-Jawahri, A.; McAfee, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Non-relapse mortality in TP53-mutated MDS/AML - A multi-center collaborative study
    Meeting Abstract

    Byrne, M. T.; Kurian, T. J.; Patel, D. A.; Tamari, R.; Hong, S.; Abdelhakim, H.; Klein, V.; Rojas, P.; Madhavan, R.; Kent, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Biologic assignment trial of reduced-intensity hematopoietic cell transplantation based on donor availability in patients 50-75 years of age with advanced myelodysplastic syndrome
    Journal Article

    Nakamura, R.; Saber, W.; Martens, M. J.; Ramirez, A.; Scott, B.; Oran, B.; Leifer, E.; Tamari, R.; Mishra, A.; Maziarz, R. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Meeting Abstract

    Bewersdorf, J. P.; Sheth, A.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save